Home › Companies › ANI PHARMACEUTICALS INC. › 2023-2024

ANI PHARMACEUTICALS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and ANI PHARMACEUTICALS INC.’s Form 8-K, filed 2024-05-23 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 11Ballot items
  • 249Asset managers
  • 3,306Fund votes
  • 2024-05-21Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ANI PHARMACEUTICALS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by ANI PHARMACEUTICALS INC.

These tallies are ANI PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-23 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ANI PHARMACEUTICALS INC. — official shareholder meeting results, meeting held 2024-05-21
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Thomas Haughey 14,837,6192,060,36315,911 --1,192,463 Majority: yes
Elect Director: Nikhil Lalwani 16,838,89868,1256,870 --1,192,463 Majority: yes
Elect Director: Matthew J. Leonard, R.Ph. 16,286,549615,18112,163 --1,192,463 Majority: yes
Elect Director: Antonio R. Pera 16,451,771447,40414,718 --1,192,463 Majority: yes
Elect Director: Muthusamy Shanmugam 16,785,294116,44412,155 --1,192,463 Majority: yes
Elect Director: Renee P. Tannenbaum, Pharm.D. 15,830,1871,068,99314,713 --1,192,463 Majority: yes
Elect Director: Jeanne A. Thoma 16,487,783411,40114,709 --1,192,463 Majority: yes
Elect Director: Patrick D. Walsh 16,477,655424,15012,088 --1,192,463 Majority: yes
Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year endi 18,043,07856,7356,543 ---- Majority: yes
Proposal 3: Approval of the Say-on-Pay Proposal The vote with respect to the approval of the Company's named executive officers, on an advisory basis, was as follows: 16,139,473762,71811,702 --1,192,463 Majority: yes
Proposal 4: Approval o f the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan was as follows: 16,031,866871,20410,823 --1,192,463 Majority: yes

Source: ANI PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-05-23 — read the filing on EDGAR.

How asset managers voted at the ANI PHARMACEUTICALS INC. 2023-2024 meeting

Each item below shows how the 249 asset managers that disclosed a ANI PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve the compensation of the Company's named executive officers, on an advisory basis;

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 13 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 16,139,473AGAINST: 762,718

ANI PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Approval of the Say-on-Pay Proposal The vote with respect to the approval of the Company's named executive officers, on an advisory basis, was as follows:”): 16,139,473 for, 762,718 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 76% for, 4% against (80% of the company cast a for/against vote).

The 246 asset managers below cast 94% of the shares they voted on this item FOR (13,344,588 for, 821,611 against).

FOR 94%
FOR: 13,344,588 (94.2%)AGAINST: 821,611 (5.8%)ABSTAIN: 5,959 (0.0%)NOT VOTED: 200 (0.0%)
Largest asset managers voting on “To approve the compensation of the Company's named executive officers, on an advisory basis;” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock2,376,7590 00For
Vanguard1,307,6720 00For
Rubric Capital Management LP925,1960 00For
State Street809,4170 00For
Deep Track Capital, LP769,8990 00For
Dimensional582,6980 00For
Invesco446,3740 00For
Charles Schwab386,5580 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC364,0950 00For
Ranger Investment Management, L.P.348,0330 00For
GEODE CAPITAL MANAGEMENT, LLC339,0780 00For
Fidelity326,8520 00For
Global Alpha Capital Management Ltd.0288,485 00Against
JPMorgan285,4130 00For
Nuveen231,4460 00For
TIAA230,7080 00For
Columbia Threadneedle217,1010 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST214,5170 00For
KENNEDY CAPITAL MANAGEMENT LLC198,2330 00For
WILLIAM BLAIR FUNDS194,9100 00For
SEI184,7770 00For
Northern Trust161,21712 00For
THOMPSON SIEGEL & WALMSLEY LLC146,7980 00For
Waddell & Reed138,8600 00For
Desjardins Global Asset Management Inc.0132,375 00Against

Showing the 25 largest of 246 asset managers. See all 246 in the interactive database.

2. To approve the Amended and Restated 2022 Stock Incentive Plan.

COMPENSATIONMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 16,031,866AGAINST: 871,204

ANI PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Approval o f the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan was as follows:”): 16,031,866 for, 871,204 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 76% for, 4% against (80% of the company cast a for/against vote).

The 92 asset managers below cast 98% of the shares they voted on this item FOR (6,397,413 for, 125,081 against).

FOR 98%
FOR: 6,397,413 (98.1%)AGAINST: 125,081 (1.9%)ABSTAIN: 1,630 (0.0%)
Largest asset managers voting on “To approve the Amended and Restated 2022 Stock Incentive Plan.” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,774,7740 00For
Vanguard1,270,3640 00For
Dimensional507,7710 00For
Fidelity326,4070 00For
State Street274,91823 00For
TIAA230,7080 00For
Invesco221,1300 00For
Columbia Threadneedle217,1010 00For
WILLIAM BLAIR FUNDS194,9100 00For
Charles Schwab190,2190 00For
Waddell & Reed138,8600 00For
JPMorgan114,8170 00For
SEI92,1810 00For
World Funds Trust7,10065,509 00Against
Russell Investments69,8670 00For
Empower67,2170 00For
Brighthouse63,0120 1,6300For
Loomis Sayles47,1560 00For
OBERWEIS FUNDS43,5000 00For
American Century041,604 00Against
Equitable39,0520 00For
Jackson National38,5060 00For
Prudential/PGIM31,2540 00For
Transamerica30,1210 00For
AIG/SunAmerica29,6660 00For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

3. Election of Directors: Antonio R. Pera

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 16,451,771AGAINST: 447,404

ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Antonio R. Pera”): 16,451,771 for, 447,404 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 78% for, 2% against (80% of the company cast a for/against vote).

The 89 asset managers below cast 99.9% of the shares they voted on this item FOR (6,501,186 for, 48 against).

FOR 99.9%
FOR: 6,501,186 (100.0%)AGAINST: 48 (0.0%)ABSTAIN: 1,630 (0.0%)
Largest asset managers voting on “Election of Directors: Antonio R. Pera” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,774,7740 00For
Vanguard1,270,3640 00For
Dimensional507,7710 00For
Fidelity326,4070 00For
State Street274,89348 00For
TIAA230,7080 00For
Invesco221,1300 00For
Columbia Threadneedle217,1010 00For
WILLIAM BLAIR FUNDS194,9100 00For
Charles Schwab190,2190 00For
Waddell & Reed138,8600 00For
JPMorgan114,8170 00For
SEI92,1810 00For
World Funds Trust72,6090 00For
Russell Investments69,8670 00For
Empower67,2170 00For
Brighthouse63,0120 1,6300For
Loomis Sayles47,1560 00For
OBERWEIS FUNDS43,5000 00For
American Century41,6040 00For
Equitable39,0520 00For
Jackson National38,5060 00For
Prudential/PGIM31,2540 00For
Transamerica30,1210 00For
AIG/SunAmerica29,6660 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

4. Election of Directors: Jeanne A. Thoma

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 16,487,783AGAINST: 411,401

ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jeanne A. Thoma”): 16,487,783 for, 411,401 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 78% for, 2% against (80% of the company cast a for/against vote).

The 89 asset managers below cast 99.9% of the shares they voted on this item FOR (6,501,186 for, 48 against).

FOR 99.9%
FOR: 6,501,186 (100.0%)AGAINST: 48 (0.0%)ABSTAIN: 1,630 (0.0%)
Largest asset managers voting on “Election of Directors: Jeanne A. Thoma” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,774,7740 00For
Vanguard1,270,3640 00For
Dimensional507,7710 00For
Fidelity326,4070 00For
State Street274,89348 00For
TIAA230,7080 00For
Invesco221,1300 00For
Columbia Threadneedle217,1010 00For
WILLIAM BLAIR FUNDS194,9100 00For
Charles Schwab190,2190 00For
Waddell & Reed138,8600 00For
JPMorgan114,8170 00For
SEI92,1810 00For
World Funds Trust72,6090 00For
Russell Investments69,8670 00For
Empower67,2170 00For
Brighthouse63,0120 1,6300For
Loomis Sayles47,1560 00For
OBERWEIS FUNDS43,5000 00For
American Century41,6040 00For
Equitable39,0520 00For
Jackson National38,5060 00For
Prudential/PGIM31,2540 00For
Transamerica30,1210 00For
AIG/SunAmerica29,6660 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

5. Election of Directors: Matthew J. Leonard, R.Ph.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 16,286,549AGAINST: 615,181

ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Matthew J. Leonard, R.Ph.”): 16,286,549 for, 615,181 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 77% for, 3% against (80% of the company cast a for/against vote).

The 89 asset managers below cast 95% of the shares they voted on this item FOR (6,168,458 for, 332,776 against).

FOR 95%
FOR: 6,168,458 (94.9%)AGAINST: 332,776 (5.1%)ABSTAIN: 1,630 (0.0%)
Largest asset managers voting on “Election of Directors: Matthew J. Leonard, R.Ph.” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,774,7740 00For
Vanguard1,270,3640 00For
Dimensional507,7710 00For
Fidelity326,4070 00For
State Street274,9410 00For
TIAA230,7080 00For
Invesco221,1300 00For
Columbia Threadneedle217,1010 00For
WILLIAM BLAIR FUNDS194,9100 00For
Charles Schwab190,2190 00For
Waddell & Reed0138,860 00Against
JPMorgan114,8170 00For
SEI92,1810 00For
World Funds Trust72,6090 00For
Russell Investments69,8670 00For
Empower11,69955,518 00Against
Brighthouse26,48836,524 1,6300Against
Loomis Sayles047,156 00Against
OBERWEIS FUNDS43,5000 00For
American Century41,6040 00For
Equitable39,0520 00For
Jackson National38,5060 00For
Prudential/PGIM15,92415,330 00For
Transamerica30,1210 00For
AIG/SunAmerica29,6660 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

6. Election of Directors: Muthusamy Shanmugam

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 16,785,294AGAINST: 116,444

ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Muthusamy Shanmugam”): 16,785,294 for, 116,444 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 80% for, 0.6% against (80% of the company cast a for/against vote).

The 89 asset managers below cast 99.9% of the shares they voted on this item FOR (6,501,186 for, 48 against).

FOR 99.9%
FOR: 6,501,186 (100.0%)AGAINST: 48 (0.0%)ABSTAIN: 1,630 (0.0%)
Largest asset managers voting on “Election of Directors: Muthusamy Shanmugam” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,774,7740 00For
Vanguard1,270,3640 00For
Dimensional507,7710 00For
Fidelity326,4070 00For
State Street274,89348 00For
TIAA230,7080 00For
Invesco221,1300 00For
Columbia Threadneedle217,1010 00For
WILLIAM BLAIR FUNDS194,9100 00For
Charles Schwab190,2190 00For
Waddell & Reed138,8600 00For
JPMorgan114,8170 00For
SEI92,1810 00For
World Funds Trust72,6090 00For
Russell Investments69,8670 00For
Empower67,2170 00For
Brighthouse63,0120 1,6300For
Loomis Sayles47,1560 00For
OBERWEIS FUNDS43,5000 00For
American Century41,6040 00For
Equitable39,0520 00For
Jackson National38,5060 00For
Prudential/PGIM31,2540 00For
Transamerica30,1210 00For
AIG/SunAmerica29,6660 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

7. Election of Directors: Nikhil Lalwani

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 16,838,898AGAINST: 68,125

ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Nikhil Lalwani”): 16,838,898 for, 68,125 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 80% for, 0.4% against (80% of the company cast a for/against vote).

The 89 asset managers below cast 99.9% of the shares they voted on this item FOR (6,501,186 for, 48 against).

FOR 99.9%
FOR: 6,501,186 (100.0%)AGAINST: 48 (0.0%)ABSTAIN: 1,630 (0.0%)
Largest asset managers voting on “Election of Directors: Nikhil Lalwani” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,774,7740 00For
Vanguard1,270,3640 00For
Dimensional507,7710 00For
Fidelity326,4070 00For
State Street274,89348 00For
TIAA230,7080 00For
Invesco221,1300 00For
Columbia Threadneedle217,1010 00For
WILLIAM BLAIR FUNDS194,9100 00For
Charles Schwab190,2190 00For
Waddell & Reed138,8600 00For
JPMorgan114,8170 00For
SEI92,1810 00For
World Funds Trust72,6090 00For
Russell Investments69,8670 00For
Empower67,2170 00For
Brighthouse63,0120 1,6300For
Loomis Sayles47,1560 00For
OBERWEIS FUNDS43,5000 00For
American Century41,6040 00For
Equitable39,0520 00For
Jackson National38,5060 00For
Prudential/PGIM31,2540 00For
Transamerica30,1210 00For
AIG/SunAmerica29,6660 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

8. Election of Directors: Patrick D. Walsh

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 16,477,655AGAINST: 424,150

ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Patrick D. Walsh”): 16,477,655 for, 424,150 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 78% for, 2% against (80% of the company cast a for/against vote).

The 89 asset managers below cast 99.7% of the shares they voted on this item FOR (6,482,013 for, 19,221 against).

FOR 99.6%
FOR: 6,482,013 (99.7%)AGAINST: 19,221 (0.3%)ABSTAIN: 1,630 (0.0%)
Largest asset managers voting on “Election of Directors: Patrick D. Walsh” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,774,7740 00For
Vanguard1,270,3640 00For
Dimensional507,7710 00For
Fidelity326,4070 00For
State Street274,89348 00For
TIAA230,7080 00For
Invesco221,1300 00For
Columbia Threadneedle217,1010 00For
WILLIAM BLAIR FUNDS194,9100 00For
Charles Schwab190,2190 00For
Waddell & Reed138,8600 00For
JPMorgan114,8170 00For
SEI92,1810 00For
World Funds Trust72,6090 00For
Russell Investments69,8670 00For
Empower55,51811,699 00For
Brighthouse63,0120 1,6300For
Loomis Sayles47,1560 00For
OBERWEIS FUNDS43,5000 00For
American Century41,6040 00For
Equitable39,0520 00For
Jackson National38,5060 00For
Prudential/PGIM31,2540 00For
Transamerica30,1210 00For
AIG/SunAmerica29,6660 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

9. Election of Directors: Renee P. Tannenbaum, Pharm.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 15,830,187AGAINST: 1,068,993

ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Renee P. Tannenbaum, Pharm.D.”): 15,830,187 for, 1,068,993 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 75% for, 5% against (80% of the company cast a for/against vote).

The 89 asset managers below cast 95% of the shares they voted on this item FOR (6,165,293 for, 335,941 against).

FOR 95%
FOR: 6,165,293 (94.8%)AGAINST: 335,941 (5.2%)ABSTAIN: 1,630 (0.0%)
Largest asset managers voting on “Election of Directors: Renee P. Tannenbaum, Pharm.D.” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,774,7740 00For
Vanguard1,270,3640 00For
Dimensional507,7710 00For
Fidelity326,4070 00For
State Street274,86378 00For
TIAA230,7080 00For
Invesco221,1300 00For
Columbia Threadneedle217,1010 00For
WILLIAM BLAIR FUNDS194,9100 00For
Charles Schwab190,2190 00For
Waddell & Reed0138,860 00Against
JPMorgan114,8170 00For
SEI92,1810 00For
World Funds Trust72,6090 00For
Russell Investments69,8670 00For
Empower11,69955,518 00Against
Brighthouse26,48836,524 1,6300Against
Loomis Sayles047,156 00Against
OBERWEIS FUNDS43,5000 00For
American Century41,6040 00For
Equitable39,0520 00For
Jackson National38,5060 00For
Prudential/PGIM15,92415,330 00For
Transamerica30,1210 00For
AIG/SunAmerica29,6660 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

10. Election of Directors: Thomas Haughey

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%
FOR: 14,837,619AGAINST: 2,060,363

ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Thomas Haughey”): 14,837,619 for, 2,060,363 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 70% for, 10% against (80% of the company cast a for/against vote).

The 89 asset managers below cast 86% of the shares they voted on this item FOR (5,558,885 for, 942,349 against).

FOR 85%AGAINST 14%
FOR: 5,558,885 (85.5%)AGAINST: 942,349 (14.5%)ABSTAIN: 1,630 (0.0%)
Largest asset managers voting on “Election of Directors: Thomas Haughey” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,774,7740 00For
Vanguard1,270,3640 00For
Dimensional507,7710 00For
Fidelity326,4070 00For
State Street22,825252,116 00Against
TIAA230,7080 00For
Invesco221,1300 00For
Columbia Threadneedle0217,101 00Against
WILLIAM BLAIR FUNDS194,9100 00For
Charles Schwab190,2190 00For
Waddell & Reed0138,860 00Against
JPMorgan114,8170 00For
SEI092,181 00Against
World Funds Trust72,6090 00For
Russell Investments69,8670 00For
Empower067,217 00Against
Brighthouse26,48836,524 1,6300Against
Loomis Sayles047,156 00Against
OBERWEIS FUNDS43,5000 00For
American Century41,6040 00For
Equitable39,0520 00For
Jackson National38,5060 00For
Prudential/PGIM15,92415,330 00For
Transamerica30,1210 00For
AIG/SunAmerica29,6660 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

11. To ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024;

AUDIT-RELATEDMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 18,043,078AGAINST: 56,735

ANI PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of EisnerAmper LLP as the Company's independent registered public ”): 18,043,078 for, 56,735 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 85% for, 0.3% against (86% of the company cast a for/against vote).

The 89 asset managers below cast 99.9% of the shares they voted on this item FOR (6,501,211 for, 23 against).

FOR 99.9%
FOR: 6,501,211 (100.0%)AGAINST: 23 (0.0%)ABSTAIN: 1,630 (0.0%)
Largest asset managers voting on “To ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm fo” at ANI PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,774,7740 00For
Vanguard1,270,3640 00For
Dimensional507,7710 00For
Fidelity326,4070 00For
State Street274,91823 00For
TIAA230,7080 00For
Invesco221,1300 00For
Columbia Threadneedle217,1010 00For
WILLIAM BLAIR FUNDS194,9100 00For
Charles Schwab190,2190 00For
Waddell & Reed138,8600 00For
JPMorgan114,8170 00For
SEI92,1810 00For
World Funds Trust72,6090 00For
Russell Investments69,8670 00For
Empower67,2170 00For
Brighthouse63,0120 1,6300For
Loomis Sayles47,1560 00For
OBERWEIS FUNDS43,5000 00For
American Century41,6040 00For
Equitable39,0520 00For
Jackson National38,5060 00For
Prudential/PGIM31,2540 00For
Transamerica30,1210 00For
AIG/SunAmerica29,6660 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

Largest ANI PHARMACEUTICALS INC. shareholders voting in 2023-2024

Ranked by the number of ANI PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 21,108,152 shares outstanding at the time of that meeting.

Top ANI PHARMACEUTICALS INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1BlackRock 11.26%
2Vanguard 6.20%
3Rubric Capital Management LP 4.38%
4State Street 3.83%
5Deep Track Capital, LP 3.65%
6Dimensional 2.76%
7Invesco 2.11%
8Charles Schwab 1.83%
9WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.72%
10Ranger Investment Management, L.P. 1.65%

Reported ANI PHARMACEUTICALS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ANI PHARMACEUTICALS INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 12.08% 13F
Meridian Venture Partners II, L.P. 6.72% DEF14A
Robert E. Brown, Jr. 6.72% 13D
Vanguard Group 6.05% 13F
Rubric Capital Management LP 5.33% DEF14A
Muthusamy Shanmugam 4.24% DEF14A
Dimensional Fund Advisors 2.89% 13F
State Street 2.72% 13F
Nikhil Lalwani 2.26% DEF14A
Goldman Sachs 1.80% 13F

Percentages above are of 21,108,152 shares outstanding, as reported by ANI PHARMACEUTICALS INC. on its Form 10-K dated 2024-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ANI PHARMACEUTICALS INC.’s 10-K dated 2024-12-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At ANI PHARMACEUTICALS INC.'s shareholder meeting held 2024-05-21, in the 2023-2024 proxy season, 249 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 3,306 separate fund positions. On the most widely held item on that ballot — To approve the compensation of the Company's named executive officers, on an advisory basis; — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ANI PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-23.

ANI PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.